Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma: where antibody imaging dares to tread.
Bernadette V Marquez et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 55(5), 708-709 (2014-03-26)
Yin Zhang et al.
Current radiopharmaceuticals, 4(2), 131-139 (2011-12-24)
Positron emission tomography (PET) imaging with radiolabeled monoclonal antibodies has always been a dynamic area in molecular imaging. With decay half-life (3.3 d) well matched to the circulation half-lives of antibodies (usually on the order of days), (89)Zr has been...
Anjana Raut et al.
Indian journal of dental research : official publication of Indian Society for Dental Research, 22(1), 140-143 (2011-04-29)
The demand for esthetic restorations has resulted in an increased use of dental ceramics for anterior and posterior restorations. A few decades ago, all-ceramic restorations were restricted to treatment in the anterior region, but now all-ceramic restorations can be made...
Joseph R Osborne et al.
The Journal of urology, 191(5), 1439-1445 (2013-10-19)
In this pilot study we explored the feasibility of (89)Zr labeled J591 monoclonal antibody positron emission tomography of localized prostate cancer. Before scheduled radical prostatectomy 11 patients were injected intravenously with (89)Zr-J591, followed 6 days later by whole body positron...
David B N Lee et al.
ASAIO journal (American Society for Artificial Internal Organs : 1992), 56(6), 550-556 (2011-01-20)
Recent years have witnessed a rapid increase in the use of zirconium (Zr)-containing compounds in artificial internal organs. Examples include dental implants and other restorative practices, total knee and hip replacement, and middle-ear ossicular chain reconstruction. In nephrological practice, Zr-containing...